The global cell viability assays market size was USD 3.26 Billion in 2020 and is expected to register a CAGR of 8.7% during the forecast period.
The global cell viability assays market size was USD 3.26 Billion in 2020 and is expected to register a CAGR of 8.7% during the forecast period. Rising prevalence of chronic and infectious diseases, increasing focus on cell-based therapeutics, and growing private and public funding for cell-based research studies are key factors expected to drive market revenue growth over the forecast period.
Rapid rise in chronic diseases such as heart disease, obesity, diabetes, and cancer due to sedentary lifestyle, rapid urbanization, unhealthy dietary habits, and growing geriatric population is expected boost adoption of cell viability assays in research to develop efficient treatment and diagnostic methods. In addition, increasing advancements in stem cell research is expected to further contribute to revenue growth of the market over the forecast period.
Cell viability is the measurement of proportion of live and healthy cells within a population. Cell viability assays are carried out to ascertain overall health of cells, optimize experimental conditions or cell culture, and assess cell survival after treatment with compounds or reagents. Cell viability assays offer information about cell health through a thorough measurement of the cell’s metabolic activity, ATP synthesis and storage, or cell proliferation. Cell viability can also be determined through cell toxicity assays that provide data about markers of cell death.
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118261
Cell viability and cell toxicity assays are crucial tools for determining cellular responses to experimental compounds such as drugs. Cell-based assays are also extensively used to measure receptor binding and various signal transduction events that might involve gene reporter expression, trafficking of cellular components, or assessing functioning of organelles. Viability assays can be used to study success of cell culture techniques, cryopreservation techniques, toxicity of experimental substances, or efficacy of substances in reducing effects of toxic substances and this has increased its importance in stem cell research and in production of cell-based therapeutics. This is also expected to contribute significantly to revenue growth of the market going ahead.
Increasing demand for advanced healthcare infrastructure and rising expenditure on medical facilities are also expected to boost research and development of cell based therapies. Rising application of cell viability assays in quality assurance and quality control procedures in various industries such as biotechnology, food and beverages, pharmaceuticals, and water treatment, among others, is a major factor expected to drive market revenue growth over the forecast period. However, cell viability assays are time consuming and this is expected to restrain market growth to a certain extent over the forecast period. In addition, high costs associated with reagents and instruments can hamper market growth to some extent over the forecast period.
Market Dynamics:
Driver: Rising global prevalence of chronic and infectious diseases
Growing healthcare burden of chronic and lifestyle induced diseases such as cancer, heart diseases, obesity, diabetes, and arthritis, among others, have boosted demand for cell-based assays to develop quick treatment and diagnostic approaches to enable early detection. This is expected to drive revenue growth of the market over the forecast period. Increasing global geriatric population, rising prevalence of unhealthy eating habits, rapid urbanization, and sedentary lifestyle have led to increased healthcare spending. This has also increased focus on cell-based therapeutics and boosted demand for cell-based assays in research. Cell viability assays are also extensively performed to evaluate safety and efficacy of drugs before they can be launched in the market. In addition, increasing awareness about stem cell therapies and advancements in cancer research have also boosted demand for cell viability assays, and this is expected to further drive revenue growth of the market over the forecast period.
Restraint: Lack of skilled professionals and high costs of equipment
High costs of equipment, instrument, and reagents have hampered adoption of cell viability assay kits across small-scale healthcare settings, which is expected to restrain market growth to a certain extent going ahead. In addition, continual technological advancements has increased the costs of cell viability assay kits and this has led to additional expenditure in the healthcare sector. The advent of smart cell viability assay solutions has increased the need for expertise to prepare samples for automated assay testing. Lack of skilled professionals and technicians in the healthcare industry is expected to restrain market growth to a certain extent over the forecast period.
Related Reports:
- Ophthalmic Examination Microscope Market: https://qyresearchmedical.com/report/global-ophthalmic-examination-microscope-market-size-share-trends-and-forecast-2022-2030/117946
- Keratomes Market: https://qyresearchmedical.com/report/global-keratomes-market-size-share-trends-and-forecast-2022-2030/117945
- Dermal Substitutes Market: https://qyresearchmedical.com/report/global-dermal-substitutes-market-size-share-trends-and-forecast-2022-2030/117944
Product Outlook:
Based on product, the global cell viability assays market has been segmented into consumables and instruments. Consumables segment is expected to account for largest revenue share in the global market over the forecast period owing to rising consumption of and demand for consumables in various cell viability experiments. Consumables can be further segmented into reagents, assay kits, and microplates. Increasing investment in R&D activities in pharmaceutical and biotechnology sectors, advancements in stem cell and cancer research, and rising drug discovery and development activities are expected to drive demand for consumables over the forecast. This is expected to contribute significantly to revenue growth of this segment over the forecast period.
Application Outlook:
Based on application, the global cell viability assays market has been segmented into basic research, stem cell research, drug discovery & development, clinical & diagnostics, and others. Drug discovery and development segment is expected to register considerable revenue growth over the forecast period. Rising prevalence of chronic illnesses, lifestyle-induced diseases, and infectious diseases have boosted demand for efficient treatment approaches and novel therapeutics. Growing funding and financial support from governments for drug research and development to create novel therapies and develop new treatments for a broad spectrum of human diseases is expected to contribute significantly to revenue growth of this segment going ahead.
End-use Industry Outlook:
Based on end-use industry, the global cell viability assays market has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostics labs, and others. Pharmaceutical and biotechnology companies segment is expected to register robust revenue CAGR over the forecast period. Growth can be attributed to rising number of R&D activities in the biopharmaceutical sector, increasing focus on stem cell research, growing research to develop of new assay kits and instruments, and rising use of cell viability assays in drug research and development. Increasing application of cell viability and proliferation assays to evaluate the efficacy of experimental anti-cancer therapeutics on various cell lines to cater to growing demand for accurate diagnosis and effective therapeutic approaches for cancers is also a key factor expected to drive revenue growth of the segment over the forecast period.
Regional Outlook:
Based on regional analysis, North America is expected to account for significantly large share in terms of revenue during the forecast period. Growth can be attributed to increasing burden of infectious diseases, growing private and public funding for stem cell research, rising demand for biopharmaceuticals, and presence of state-of-the-art healthcare and research infrastructure in the region. In addition, increasing healthcare expenditure, favorable reimbursement policies, and robust presence of key companies in the region are other key factors expected to contribute to revenue growth of the market in the region.
Europe accounted for 32% revenue share in 2020 and is expected to register significant growth during the forecast period owing to increasing stem cell research activities, rising need for accurate and early diagnosis of chronic diseases, and presence of established healthcare and clinical infrastructure and facilities in the region. Asia Pacific is expected to register fastest revenue CAGR during the forecast period, attributable to increasing prevalence of chronic and infectious diseases, rising support for pharmaceutical research, and improved healthcare budget in countries in the region.
Competitive Landscape:
The global cell viability assays market is fragmented, with a number of major players operating on regional and global scale and accounting for majority market revenue. Major companies are focusing on product development and advancements and strategic alliances such as mergers and acquisitions, collaborations, and partnerships to cater to growing global demand and to gain a robust footing in the market. Major companies operating in the market include Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, Merck KGaA, GE Healthcare, BioTek Instruments, PerkinElmer, Inc., Promega Corporation, Biotium, Abcam Plc., Canvax, Danaher Corporation, and Creative Bioarray.
Some key developments in the market:
- In April 2021, Halo Labs, which is a leading life science instrumentation company that develops tools for biologics researchers, introduced the next-generation of its instrument line with the launch of Aura CL. According to the company, the Aura CL is expected to revolutionize cell therapy product quality analysis as it equipped with all the cytometric capabilities need for cell therapies and it can count cells, ID therapeutic cell types, and measure cell viability in one assay.
Segments Covered in the Report:
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the segments from 2018 to 2030. For this study, Reports and Data has segmented the global cell viability assays market based on product, application, end-use industry, and region:
Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118261
Cell Viability Assays Market Report Scope
Segments covered By Product Outlook, Application Outlook, Regional Outlook
By Product Outlook
- Consumables
- Reagents
- Assay Kits
- Tetrazolium Reduction Assay Kits
- MTT Assay Kits
- Other Tetrazolium Assay Kits
- Resazurin Cell Viability Assay Kits
- Calcein-AM Cell Viability Assay Kits
- Other Assay Kits
- Microplates
- Instruments
- Spectrophotometers
- Flow Cytometers
- Automated Cell Counters
- Cell Imaging & Analysis Systems
By Application Outlook
- Basic Research
- Stem Cell Research
- Drug Discovery & Development
- Clinical and Diagnostics
- Others
By End-use Outlook
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Labs
- Academic & Research Institutes
- Others
Regional scope
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118261/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL - http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/
https://twitter.com/qyresearchmedi